About EAVA and CardioRisk 2017

Cardiorisk is the annual congress of the Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) .Cardiorisk 2017 will be held 22 -25th of November 2017. The conference is an EGYBAC accredited event and is internationally recognised and endorced by European Atherosclerosis Society and and International atherosclerosis society.

Main Topics

LDL receptor activity: a key controller of Atherosclerosis

AF and PCI: Tailoring anti thrombotic therapy you optimize outcomes

Primary prevention in the elderly: Does it have any benefit?

Dealing with the elderly with Hypertension / DM / Dyslipidemia

Does dietary cholesterol increase CV risk?

The cholesterol paradox

Obesity

Obesity is a chronic disease

Barriers in clinical practice facing obesity

The obesity paradox

Treatment of obesity

Genetic studies and CV protection

The earlier the better

Value of Mendelian studies

Genetic screening for whom

Triglycerides And HDL

Metabolic pathways

Relation to CV events

Treatment Algorithm

Debates

Statin and vascular calcification

Statin and diabetes

Clinical Cases

Case 1 Secondary Hypertension

Case 2 Familial Hyperlipidemia

Case 3 Diabetic nephropathy

Studies

EMPA-REG Outcome

The REVEAL (Randomized Evaluation of the Effects of Anacetrapib through Lipid modification)